New patent expiration for Indivior Inc drug SUBOXONE
Annual Drug Patent Expirations for SUBOXONE Suboxone is a drug marketed by Indivior Inc and is included in two NDAs. […]
New patent expiration for Indivior Inc drug SUBOXONE Read Post »
Patent Expiration
Drug Patent Expirations for the Week of October 9, 2022
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 10,285,910 Expiration: Oct 11, 2022 See More … For more information on
Drug Patent Expirations for the Week of October 9, 2022 Read Post »
Drug Patent Expirations for the Week of October 9, 2022
SUBOXONE (buprenorphine hydrochloride; naloxone hydrochloride) Indivior inc Patent: 10,285,910 Expiration: Oct 11, 2022 See More … For more information on
Drug Patent Expirations for the Week of October 9, 2022 Read Post »
New patent expiration for Sb Pharmco drug AVANDAMET
Annual Drug Patent Expirations for AVANDAMET Avandamet is a drug marketed by Sb Pharmco and is included in one NDA.
New patent expiration for Sb Pharmco drug AVANDAMET Read Post »
New patent expiration for Boehringer Ingelheim drug MICARDIS
Annual Drug Patent Expirations for MICARDIS Micardis is a drug marketed by Boehringer Ingelheim and is included in two NDAs.
New patent expiration for Boehringer Ingelheim drug MICARDIS Read Post »
New patent expiration for Takeda Pharms drug TRINTELLIX
Annual Drug Patent Expirations for TRINTELLIX Trintellix is a drug marketed by Takeda Pharms Usa and is included in one
New patent expiration for Takeda Pharms drug TRINTELLIX Read Post »
Drug Patent Expirations for the Week of September 25, 2022
ABILIFY (aripiprazole) Otsuka Patent: 9,359,302 Expiration: Sep 25, 2022 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of September 25, 2022 Read Post »
New patent expiration for Organon drug CLARINEX D 24 HOUR
Annual Drug Patent Expirations for CLARINEX+D+24+HOUR Clarinex D 24 Hour is a drug marketed by Organon and is included in
New patent expiration for Organon drug CLARINEX D 24 HOUR Read Post »
New patent expiration for APGDI drug MYRBETRIQ GRANULES
Annual Drug Patent Expirations for MYRBETRIQ+GRANULES Myrbetriq Granules is a drug marketed by Apgdi and is included in one NDA.
New patent expiration for APGDI drug MYRBETRIQ GRANULES Read Post »
